BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

0.0739 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioXcel Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Get insights into the top gainers and losers of Friday's pre-market session. ↗

February 28, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Via Chartmill

Which stocks are experiencing notable movement on Monday? ↗

February 10, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

February 10, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

What's Next: BioXcel Therapeutics's Earnings Preview ↗

November 13, 2024

Via Benzinga

BioXcel Therapeutics's Earnings Outlook ↗

March 11, 2024

Via Benzinga

The market is filled with gapping stocks in Monday's session. ↗

February 10, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

February 07, 2025

The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

Which stocks are moving on Thursday? ↗

February 06, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Thursday's session: top gainers and losers ↗

February 06, 2025

Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Thursday's session: gap up and gap down stocks ↗

February 06, 2025

The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

What's going on in today's after hours session ↗

February 04, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket ↗

January 24, 2025

Via Benzinga

The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care

December 17, 2024

USA News Group Commentary Issued on behalf of Avant Technologies Inc. Vancouver, BC – December 17, 2024 – USA News Group News Commentary – Artificial intelligence (AI) is on the brink of becoming a...

Via FinancialNewsMedia

Topics Artificial Intelligence

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 22, 2024

Via Benzinga

Earnings Scheduled For November 14, 2024 ↗

November 14, 2024

Via Benzinga

BTAI Stock Earnings: BioXcel Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

BTAI stock results show that BioXcel Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

BioXcel Therapeutics' Approved Drug For Bipolar Disorders/Schizophrenia Shows No Evidence Of Worsening Or Withdrawal In Post-Marketing Study ↗

June 25, 2024

BioXcel Therapeutics shares topline results from an Igalmi (dexmedetomidine) sublingual film study. The 180 mcg dose demonstrated favorable safety and efficacy in reducing agitation symptoms.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 25, 2024

Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!

Via InvestorPlace

BTAI Stock Earnings: BioXcel Therapeutics Misses EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

BTAI stock results show that BioXcel Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

AI Surge Has Ended: All 7 AI Stock Categories Declined This Week ↗

April 13, 2024

From no AI category losses in February, to 3 drops in March - now all 7 fell this week, clearly indicating that that the surge in AI stock prices that began back on October 31st is, indeed, over.

Via Talk Markets

Topics Artificial Intelligence

Six Of Seven AI Stock Categories Increased This Week ↗

March 23, 2024

All but one of the 7 artificial intelligence stock categories that I analyze weekly increased in value this week. But two categories are still down MTD, suggesting that the surge in the artificial...

Via Talk Markets

Topics Artificial Intelligence

7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode ↗

March 07, 2024

Bullish speculators could have their opportunity to blow up the bears with these short-squeeze stocks to buy.

Via InvestorPlace

AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD ↗

March 04, 2024

Grand View Research says the global

Via Talk Markets

Earnings Scheduled For March 12, 2024 ↗

March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 27, 2024

Via Benzinga

AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics ↗

February 19, 2024

The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.

Via Talk Markets

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 14, 2024

Via Benzinga

Leading The Charge: Tonix Pharmaceuticals And The Future Of CNS Therapeutics

February 13, 2024

Via Get News

Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies

February 14, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:EXEL),(NYSE:PFE),(NASDAQ:BTAI),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies

February 14, 2024

From FN Media Group LLC

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.